Raphael Landovitz, University of California, Los Angeles (UCLA)
University of California, Los Angeles (UCLA)Presenter Of 1 Presentation
Oral abstract session
HPTN083 interim results: Pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is safe and highly effective for cisgender men and transgender women who have sex with men (MSM,TGW)
Session Name
Room
Prime Channel-Live sessions
Presenter Of 1 Presentation
Bridging session
Long-acting injectables for HIV Rx and prevention
Session Name
Room
Symposia and bridging sessions On-Demand Channel
Presenter Of 1 Presentation
Oral abstract session
OAXLB0101 - HPTN083 interim results: Pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is safe and highly effective for cisgender men and transgender women who have sex with men (MSM,TGW)
Session Name
Room
Prime Channel-Live sessions
Presenter Of 1 Presentation
Bridging session
Long-acting injectables for HIV Rx and prevention
Session Name
Room
Symposia and bridging sessions On-Demand Channel
Presenter Of 2 Presentations
Bridging session
Long-acting injectables for HIV Rx and prevention
Session Name
Room
Symposia and bridging sessions On-Demand Channel
Oral abstract session
HPTN083 interim results: Pre-exposure prophylaxis (PrEP) containing long-acting injectable cabotegravir (CAB-LA) is safe and highly effective for cisgender men and transgender women who have sex with men (MSM,TGW)
Session Name
Room
Prime Channel-Live sessions